Clinical Trials Insight: 700009583
Latest Information Update: 18 Jan 2010
At a glance
- Drugs MEM 1003 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Memory Pharmaceuticals
- 01 Dec 2005 New trial record.
Latest Information Update: 18 Jan 2010